Skip to main content
Equibles

FIRST TRUST ADVISORS LP

Position in NEO — Neogenomics Inc

CIK 1125816 Wheaton, IL
Back to NEO Full portfolio

Position in NEO

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$147,552,477
+$101,827,685 QoQ
Shares Held
10,113,261
+64.1% QoQ
Ownership
7.87%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#3
of 266 holders
Holding Since
Mar 2020
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NEO Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

FIRST TRUST ADVISORS LP holds $1,364,038,790 across 24 Diagnostics & Research names. NEO ranks #3 (10.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 A
Agilent Technologies, Inc.
 2,079,578 $276,230,345
2 ILMN
Illumina, Inc.
 907,489 $159,563,790
3 NEO
Neogenomics Inc
This page 		10,113,261 $147,552,477
4 VCYT
Veracyte, Inc.
 2,507,902 $147,289,084
5 NTRA
Natera, Inc.
 511,214 $138,769,040
6 IDXX
Idexx Laboratories Inc /De
 202,754 $106,737,815
7 WAT
Waters Corp /De/
 272,470 $102,187,148
8 DGX
Quest Diagnostics Inc
 290,970 $61,671,091

All Filings in NEO

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $147,552,477 10,113,261
2026-03-31 $45,724,792 6,162,371
2025-03-31 $2,144,227 225,946
2024-12-31 $2,178,326 132,180
2024-09-30 $467,648 31,705
2024-06-30 $1,214,082 87,533
2024-03-31 $3,105,171 197,530
2023-12-31 $916,224 56,627
2023-03-31 $934,359 53,668
2022-09-30 $1,321,127 153,441
2022-06-30 $783,687 96,158
2021-12-31 $1,612,647 47,264
2021-06-30 $644,892 14,277
2021-03-31 $4,796,232 99,445
2020-12-31 $5,721,092 106,261
2020-09-30 $3,484,223 94,449
2020-06-30 $4,129,912 133,309
2020-03-31 $2,743,219 99,356